Your hormones could be fuelling cancer. Here's what every woman and man needs to know
2. Ovarian Cancer: Research indicates that a woman's chance of developing ovarian cancer may be influenced by hormonal factors, such as the number of ovulatory cycles she undergoes. Disorders that ...
The American Journal of Managed Care27m
Atezolizumab Fails to Help in High-Risk Triple-Negative Breast Cancer
Atezolizumab (Tecentriq) plus chemotherapy after surgery did not improve survival in high-risk triple-negative breast cancer, according to a global phase 3 trial.
Targeted Oncology27m
A Real-Time Cancer-Detecting System for Breast Cancer Goes Live
The LumiSystem is a detection tool that uses fluorescence imaging technology during lumpectomy, offering a more complete resection vs other detection systems that evaluate tissue after surgical ...
Atossa Genetics stock hits 52-week low at $0.75
In a challenging market environment, Atossa Genetics Inc . (NASDAQ:ATOS) stock has touched a 52-week low, reaching a price level of $0.75. This latest dip underscores a period of volatility for the ...